Previous 10 | Next 10 |
2023-04-27 06:00:00 ET You may have come into contact many times with McKesson (NYSE: MCK) without even realizing it. The healthcare company doesn't develop drugs, but it distributes a lot of the pharmaceutical products sold today. And in this behind-the-scenes role, McKesson has ex...
2023-04-22 03:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy’s ...
2023-04-19 06:00:00 ET Warren Buffett's portfolio is filled with strong businesses that have proven themselves over time. Some actually pay shareholders just for owning them -- like dividend stocks. At the helm of Berkshire Hathaway , Buffett has driven a compounded annual gain of more ...
2023-04-17 09:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-13 09:53:00 ET McKesson (NYSE: MCK) is a great stock for long-term holders, but many investors are not familiar with it. This medical distribution giant is anything but flashy, and you're unlikely to see its shares skyrocketing in any given period. But the truth is that ...
2023-04-12 08:00:00 ET Even if you've never heard of McKesson , (NYSE: MCK) you've almost certainly experienced the benefits of the healthcare supplies it distributes. But this company does far more than move goods from one place to another; it gives the healthcare system the raw ma...
2023-04-11 10:15:00 ET McKesson (NYSE: MCK) isn't an obvious pick for most investors. It doesn't seem to grow very fast, and there aren't any clear catalysts for it to do so in the future. Still, investors like Warren Buffett probably aren't wrong about the stock's merits. ...
2023-04-07 18:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-07 11:03:02 ET Summary The following is a dividend portfolio strategy for large caps that score the highest amongst Joel Greenblatt's Magic Formula screener. The list follows large caps that have dividends. The dividend yield kicker is added to the final score to enhan...
2023-04-07 08:10:00 ET There's nothing that markets dislike more than uncertainty. And over the last year and counting, the market has been fixated on concerns such as the prospects of a recession and geopolitical turmoil in Eastern Europe. This is precisely why the S&P 500 index ha...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-09 08:00:06 ET Eric Coldwell from Robert W. Baird issued a price target of $694.00 for MCK on 2024-07-09 06:48:00. The adjusted price target was set to $694.00. At the time of the announcement, MCK was trading at $589.53. The overall price target consensus is at ...
2024-07-09 00:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...